3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
15
HER2-positive Breast Cancer
4
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Salivary Gland Neoplasms
1
Non-squamous NSCLC
1
Non Small Cell Lung
1
Lung Neoplasms
1
Locally Advanced Breast Cancer
1
HER2-positive Early Breast Cancer
1
HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
1
Breast Cancer Invasive
1
Breast Cancer Female
1
Advanced Digestive System Tumor
1
Advanced Breast Cancer
1
Interventions
Bevacizumab
119
Fluorouracil
91
Leucovorin
83
Cetuximab
83
Oxaliplatin
80
pembrolizumab
70
Irinotecan
67
Nivolumab
46
Capecitabine
43
Specimen Handling
40
regorafenib
30
Folfox protocol
29
trifluridine tipiracil drug combination
28
Magnetic Resonance Spectroscopy
27
Biopsy
27
Panitumumab
26
Standard of Care
25
HMPL-013
25
IFL protocol
21
Gemcitabine
20
Blood Specimen Collection
19
atezolizumab
18
Trifluridine
18
Cisplatin
18
tislelizumab
17
balstilimab
16
Colonoscopy
16
Carboplatin
16
encorafenib
15
Paclitaxel
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
pyrotinib
×
1 year
×
Clear all
No trials found.